Robin A. Wilson

An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation.

K. Moore, E. Fisher, R. Ramasamy, 2020, Circulation research.

Abstract 11561: Pharmacological Inhibition of Rage/diaph1 Axis Enhances Weight Loss in Diet Induced Obese Mice and Improves Glucose Homeostasis

R. Ramasamy, A. Schmidt, M. Manigrasso, 2021, Circulation.

Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease

C. Vásquez, R. Ramasamy, A. Schmidt, 2021, Immunometabolism.

The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease.

M. Sevick, R. Ramasamy, A. Schmidt, 2022, Cardiovascular research.

Pharmacological antagonism of receptor for advanced glycation end products signaling promotes thermogenesis, healthful body mass and composition, and metabolism in mice

R. Ramasamy, A. Schmidt, Huilin Li, 2023, Obesity.